Replies to post #4895 on Keep It Quick Reviews

[PoemStone]

DYAX. Dyax Corp. and Kadmon Sign Strategic Licensing Agreement for DX-2400
Novel MMP-14 Inhibitor to be Developed in Multi-Indication Oncology Program
http://finance.yahoo.com/news/dyax-corp-kadmon-sign-strategic-113000340.html